Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.
Murph
Mandi M
MM
Smith
Debra L
DL
Hennessy
Bryan
B
Lu
Yiling
Y
Joy
Corwin
C
Coombes
Kevin R
KR
Mills
Gordon B
GB
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002986:Clinical Trials as Topic; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D019869:Phosphatidylinositol 3-Kinases; D040901:Proteomics / Q000379:methods* / Q000639:trends
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D019869:Phosphatidylinositol 3-Kinases